Skip to main content
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
editorial
. 2006 Feb;40(2):96–97. doi: 10.1136/bjsm.2005.020719

Monitoring of serum enzymes in sport

P Brancaccio 1,2, F M Limongelli 1,2, N Maffulli 1,2
PMCID: PMC2492050  PMID: 16431993

Short abstract

Monitoring of creatine kinase and lactate dehydrogenase can reveal the state of the muscle and its biochemical adaptation to physical load

Keywords: exercise, muscle pathology, serum enzymes, training


Functional assessment of athletes' fitness includes a variety of variables. Serum creatine kinase (CK) and lactate dehydrogenase (LDH) give an indication of the degree of metabolic adaptation to physical training of skeletal muscles. Both enzymes are involved in muscle metabolism, and their serum concentration is normally very low, a result of physiological wear and tear of the cell. They increase considerably after intensive exercise and in muscle pathology.1,2

Changes in serum activity of muscle enzymes have been reported in normal subjects and athletes after strenuous exercise.3,4,5,6 The amount of enzyme efflux from muscle tissue to serum can be influenced by physical exercise.7 Also, there are ethnic differences,8 and the differences between the sexes have been attributed to the protective effects of oestrogen on muscle cell membrane.9

Muscle biopsy findings have evidenced different activity of total LDH and LDH isozymes in endurance and strength athletes. The former had lower total LDH with a prevalence of LDH1–2 isoenzyme activity compared with the latter, who showed higher total LDH and prevalence of LDH5 activity. In addition, LDH and CK activity measured by needle biopsy showed different behaviour before and after training, and changes due to different protocols and intensity and level of training.10,11,12,13 This is especially true for CK, the isoenzymes of which can be identified in different organs: CK1(BB) is mainly from the brain, CK2(MB) is mainly cardiac, and CK3(MM) is mainly from skeletal muscle.

Monitoring of CK and characterisation of its isoenzymes is widely used in the diagnosis of cardiomyopathies, encephalopathies, and muscle disease.14,15,16 CK activity may increase after treatment with cholesterol lowering drugs, asthma, hypothyroidism, recreational drug use, and anabolic androgenic steroid abuse.17 Also, increased CK activity from rhabdomyolysis is found during and after exercise.18,19 In this instance, high CK activity correlates with physical training status, with large increases in CK after exercise. Most data on CK monitoring come from long distance runners, although short intense periods of sports activity seem to induce increases in serum CK, especially if eccentric muscle contractions have been involved.12 In these instances, the high serum CK activity is a consequence of damage to sarcolemmal membrane.20,21 The damage is probably proportional to the duration and intensity of the contraction, and is related to the severity of muscle soreness. A peak is reached 24 hours after the end of the exercise, and CK activity may stay raised for 48–72 hours.

High serum CK activity in apparently healthy subjects at rest and without other factors should therefore prompt further investigations; once secondary rhabdomyolysis is excluded, it may be a sign of a genetic muscle disease.22 Muscle biopsy is helpful for diagnosis in asymptomatic subjects with high serum CK activity: 18% of such patients had a muscle disease, 38.6% non‐specific muscle anomalies, and 31.6% were normal.23,24

High CK activity after a period of complete rest in an athlete is unexpected, as physical training also exerts a positive effect on the sarcolemma. Most data from the literature evidence that the resting CK activity is higher in athletes, but, in the absence of trauma, drugs, or other pathologies, increases after exercise are lower than those recorded in matched healthy control subjects.25 Hence, persistently high CK activity may be a sign of a subclinical genetic muscle disease, which training loads may evidence through the onset of symptoms such as profound fatigue and abnormal contractions.26

Recently, several studies have identified numerous muscle diseases with a variety of clinical manifestations. For example, Mongini et al27 have documented a patient with high serum CK activity with mild myoglobinuria at rest and decreased muscle function associated with changes in α sarcoglycan. Also, other patients have shown McArdle syndrome, and some patients with muscle dystrophy show mutation of the gene for caveolin.28 In others, high serum CK activity may be a sign of malignant hyperthermia, with no significant relation between the basal serum CK activity and the severity of the condition.29 In some patients, the muscle condition may be phenotypically expressed as a cardiomyopathy.30

High serum CK activity in an athlete after absolute rest and without any further predisposing factors should prompt a full diagnostic work up with particular regard to signs of muscle weakness or other simple signs that, in both athletes and sedentary subjects, are not always promptly evident. These include cranial asymmetry and evaluation of symmetry of the inferior angle of the scapula and the iliac spines.31,32,33 Stiffness and muscle soreness are a normal consequence of physical training. However, if they are resistant to rest and massage, or recur too often, they should prompt a diagnostic work up.

Further minimally invasive investigations include examination of the isoenzymes of CK (CK‐MM, CK‐MB, CK‐BB) and LDH (LDH1, LDH2, LDH3, LDH4, LDH5) at rest and after exercise. In healthy athletes, serum CK activity peaks six hours after exercise and returns to normal within 48 hours.

“A symptomatically high CK activity may be a predictor of late onset cardiomyopathy”

Normally, only CK‐MM is present in the serum; the presence of other isoenzymes should be considered suspicious. CK‐MB is present in ultramarathon runners,34 and CK‐BB in boxers,35 but the presence of these isoenzymes at rest or after a laboratory exercise test should be considered a sign of pathology. A symptomatically high CK activity may be a predictor of late onset cardiomyopathy, which can be difficult to identify, especially in subjects who practice endurance sports. In these instances, it may be necessary to perform serial echocardiography to identify the possible onset of the condition.

The isoenzymes of LDH give a different picture from CK with regard to metabolic adaptation to exercise, with different profiles in power and endurance athletes. Therefore the study of the isoenzymes of CK and LDH produces information not only on the state of the muscle but also on its biochemical adaptation to physical load. Often patients with persistent high CK activity also have altered LDH profiles. The protocol for studying an athlete with recurrent muscle problems with known high CK activity should include accurate clinical examination to detect the asymmetries outlined above, together with localised atrophic or hypotonic muscles. Echocardiography may reveal heart problems, which can themselves be responsible for high CK activity, as some genetic cardiomyopathies may present late with cardiac involvement.36 A maximal exercise test should be performed to evaluate CK and LDH isoenzymes at baseline, 30 minutes, six hours, 24 hours, 48 hours, and 72 hours after the tests. In this way, it is possible to study the serum kinetics of these enzymes. The evaluation should also include serum lactate concentrations at baseline, at peak effort, and 5–10 minutes after the tests.37 A urinalysis should reveal exercise myoglobinuria.38 If CK and LDH activities are persistently altered, then it may be necessary to perform a muscle biopsy. If the subject is asymptomatic and if light microscopy reveals no gross morphological changes at muscle biopsy, biochemical and genetic tests must be performed to exclude a pre‐clinical or carrier status of a genetic disease or a metabolic disorder such as carnitine palmitoyltransferase deficiency.39 If these tests are negative, then idiopathic high CK activity may be present. To our knowledge, there are no studies on the effects of repeated exercise bouts on athletes with persistent high CK activity. Therefore, if the athlete is totally asymptomatic, it is difficult to evaluate the risks of sporting activities. It is, however, possible that repeated intense prolonged exercise may produce negative effects, as it does not induce the physiological muscle adaptations to physical training given the continuous loss of muscle proteins. Indeed, in muscles of syntrophin deficient subjects after exercise, muscle hypertrophy occurs with formation of abnormal neuromuscular junctions.40

It is probably safe to counsel the athlete to continue to undertake physical activity at a lower intensity, so as to prevent muscle damage from high intensity exercise, and allowing ample recovery time.

In conclusion, further clinical examination and investigations should be performed to identify the possible causes of muscle pathology at the basis of persistent high serum CK activity. In this respect, athletes with persistently high CK activity at rest should be considered exactly as all other subjects in the same condition and directly undergo muscle biopsy to try to achieve a diagnosis.

Once a diagnosis has been formulated, physical activity should be tailored to the physical and sporting needs of the individual. However, to date this can only be undertaken on a trial and error basis.

Footnotes

Competing interests: none declared

References

  • 1.Garry J P, McShane J M. Postcompetition elevation of muscle enzyme levels in professional football players. MedGenMed 20002E4. [PubMed] [Google Scholar]
  • 2.Hood D, Van Lente F, Estes M. Serum enzyme alteration in chronic muscle disease. A biopsy‐based diagnostic assessment. Am J Clin Pathol 199195402–407. [DOI] [PubMed] [Google Scholar]
  • 3.Wolf P L, Lott J A, Nitti G J.et al Changes in serum enzymes, lactate and haptoglobin following acute physical stress in international‐class athletes. Clin Biochem 19872073–77. [DOI] [PubMed] [Google Scholar]
  • 4.Priest J B, Oei T O, Moorehead W R. Exercise‐induce changes in common laboratory test. Am J Clin Pathol 198277285–289. [DOI] [PubMed] [Google Scholar]
  • 5.Ide M, Tajima F, Forusawa K.et al Wheelchair marathon racing causes striated muscle distress in individuals with spinal cord injury. Arch Phys Med Rehabil 199980324–327. [DOI] [PubMed] [Google Scholar]
  • 6.Munjal D D, McFadden J A, Matixet al Changes in serum myoglobin, total creatine kinase, lactate dehydrogenase and creatine kinase MB levels in runners. Clin Biochem 198316195–199. [DOI] [PubMed] [Google Scholar]
  • 7.Boros‐Hatfaludy S, Fekete G, Apor P. Metabolic enzyme activity patterns in muscle biopsy samples in different athletes. Eur J Appl Physiol Occup Physiol 198655334–338. [DOI] [PubMed] [Google Scholar]
  • 8.Gledhill R F, Van der Merwe C A, Greyling M.et al Race‐gender differences in serum creatine kinase activity: a study among South Africans. J Neurol Neurosurg Psychiatry 198851301–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Clarkson P M, Hubal M J. Are women less susceptible to exercise‐induced muscle damage? Curr Opin Clin Nutr Metab Care 20014527–531. [DOI] [PubMed] [Google Scholar]
  • 10.Klapcinska B, Iskra J, Poprzecki S.et al The effects of sprint (300 m) running on plasma lactate, uric acid, creatine kinase and lactate dehydrogenase in competitive hurdlers and untrained men. J Sports Med Phys Fit 200141306–311. [PubMed] [Google Scholar]
  • 11.Ohkuwa T, Saito M, Miyamura M. Plasma LDH and CK activities after 400 m sprinting by well‐trained sprint runners. Eur J Appl Physiol 198452296–299. [DOI] [PubMed] [Google Scholar]
  • 12.Favero T G, Stavrianeas S, Klug G A. Training‐induced alteration in lactate dehydrogenase reaction kinetics in rats: a re‐examination. Exp Physiol 199984989–998. [PubMed] [Google Scholar]
  • 13.Szabo A, Romvari R, Bogner P.et al Metabolic changes induced by regular submaximal aerobic exercise in meat‐type rabbits. Acta Vet Hung 200351503–512. [DOI] [PubMed] [Google Scholar]
  • 14.Hina K, Kusachi S, Iwasaki K.et al Use of serum creatine kinase MM isoforms for predicting the progression of left ventricular dilatation in patients with hypertrophic cardiomyopathy. Jpn Circ J 199761315–322. [DOI] [PubMed] [Google Scholar]
  • 15.Kloss R, Keller H E, Stober T.et al Creatine kinase BB activity in the serum of patients with cerebrovascular diseases. Nervenarzt 198556417–422. [PubMed] [Google Scholar]
  • 16.Hoffman E P, Clemens P R. HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies and merosinopathies. Curr Opin Rheumatol 19968528–538. [DOI] [PubMed] [Google Scholar]
  • 17.Boone J B, Jr, Lambert C P, Flynn Mg.et al Resistance exercise effects on plasma cortisol, testosterone and creatine kinase activity in anabolic‐androgenic steroid users. Int J Sports Med 199011293–297. [DOI] [PubMed] [Google Scholar]
  • 18.Boffi F M, Cittar J, Balskus G.et al Training induced apoptosis in skeletal muscle. Equine Vet J Suppl 200234275–278. [DOI] [PubMed] [Google Scholar]
  • 19.Maxwell J H, Bloor C M. Effects of conditioning on exertional rhabdomyolysis and serum creatine kinase after severe exercise. Enzyme 198126177–181. [DOI] [PubMed] [Google Scholar]
  • 20.Lee J, Goldfarb A H, Rescino M H.et al Eccentric exercise effect on blood oxidative‐stress markers and delayed onset of muscle soreness. Med Sci Sports Exerc 200234443–448. [DOI] [PubMed] [Google Scholar]
  • 21.Takagi Y, Yasuhara T, Gomi K. Creatine kinase and its isozymes. Rinsho Byori 2001116(suppl)52–61. [PubMed] [Google Scholar]
  • 22.Bruno C, Bertini E, Santorelli F M.et al Hyperckemia as the only sign of McArdle's disease in a child. J Child Neurol 200015137–138. [DOI] [PubMed] [Google Scholar]
  • 23.Prelle A, Rigoletto C, Moggio M.et al Asymptomatic familial hyperCKemia associated with desmin accumulation in skeletal muscle. J Neurol Sci 1996140132–136. [DOI] [PubMed] [Google Scholar]
  • 24.Prelle A, Tancredi L, Sciacco M.et al Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002249305–311. [DOI] [PubMed] [Google Scholar]
  • 25.Vincent H K, Vincent K R. The effect of training status on the serum creatine kinase response, soreness and muscle function following resistance exercise. Int J Sports Med 199718431–437. [DOI] [PubMed] [Google Scholar]
  • 26.Angelini C. Limb‐girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms. Acta Myol 200423130–136. [PubMed] [Google Scholar]
  • 27.Mongini T, Doriguzzi C, Bosone I.et al Alpha‐sarcoglycan deficiency featuring exercise intolerance and myoglobinuria. Neuropediatrics 200233109–111. [DOI] [PubMed] [Google Scholar]
  • 28.Carbone I, Bruno C, Sotgia F.et al Mutation in the CAV3 gene causes partial caveolin‐3 deficiency and hyperCKemia. Neurology. 2000 28 541373–1376. [DOI] [PubMed] [Google Scholar]
  • 29.Weglinski M R, Wedel D J, Engel A G. Malignant hyperthermia testing in patient with persistently increased serum creatine kinase levels. Anesth Analg 1997841038–1041. [DOI] [PubMed] [Google Scholar]
  • 30.Feng J, Yan J, Buzin C H.et al Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab 200277)119–126. [DOI] [PubMed] [Google Scholar]
  • 31.Cavanagh N P, Preece M A. Calf hypertrophy and asimmetry in female carriers of X‐linked Duchenne muscular dystrophy: an over‐diagnosed clinical manifestation. Clin Genet 198120168–172. [DOI] [PubMed] [Google Scholar]
  • 32.Mahjneh I, Haravuori H, Paetau A.et al A distinct phenotype of distal myopathy in a large Finnish family. Neurology 20036187–92. [DOI] [PubMed] [Google Scholar]
  • 33.Bonnemann C G, Bushby K. The limb‐girdle muscular dystrophies. In: Hengel AG, Franzini C, eds. Myology. 3rd ed. 371089–1092. [Google Scholar]
  • 34.Lucia A, Moran M, Perez M.et al Short‐term effects of marathon running in master runners: no evidence of myocardial injury. Int J Sports Med 199920482–486. [DOI] [PubMed] [Google Scholar]
  • 35.Brayne C E, Dow L, Calloway S P.et al Blood creatine kinase isoenzyme BB in boxers. Lancet. 1982 11 21308–1309. [DOI] [PubMed] [Google Scholar]
  • 36.Gunkel O, Reichenbach H, Thamm B.et al Late diagnosis of Curshmann‐Steinert myotonic dystrophy in a female patient with dilated cardiomyopathy and in her son. Z Kardiol 200089599–605. [DOI] [PubMed] [Google Scholar]
  • 37.Finsterer J, Milvay E. Lactate stress testing in 155 patient with mitochondriopathy. Can J Neurol Sci 20022949–53. [DOI] [PubMed] [Google Scholar]
  • 38.Lin A C, Lin C M, Wang T L.et al Rhabdomyolysis in 119 students after repetitive exercise. Br J Sports Med 200539e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Olpin S E, Allen J, Bonham J R.et al Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 20012435–42. [DOI] [PubMed] [Google Scholar]
  • 40.Hosaka Y, Yokota T, Miyagoe‐Suzuki Y.et al α1‐Syntrophin‐deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junction during regeneration. J Cell Biol 20021581097–1107. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES